Ilya Pharma

Ilya Pharma Overview

  • Founded
  • 2016
  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 6

Ilya Pharma General Information


Developer of next-generation biological drugs intended to treat wounds in skin and mucosa. The company's biological drug technology is a novel drug delivery system where lactic acid bacteria are used as vectors to produce and deliver biological drugs on site to skin wounds or in the gastrointestinal tract, its human therapeutic proteins are delivered on site in wounds by living lactic acid bacteria acting like small bioreactors, enabling patients with diabetes to get accelerated healing of a chronic wound in a cost effective way.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Delivery
Other Industries
Drug Discovery
Primary Office
  • St Göransgatan 23
  • 753 26 Uppsala
  • Sweden
+46 070-636 00 00

Ilya Pharma Timeline

Financing Round
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Ilya Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Accelerator/Incubator 00000 Completed Startup
4. Grant 20-Dec-2017 00.000 00000 Completed Startup
3. Angel (individual) 10-Jul-2017 00000 00000 Completed Startup
2. Accelerator/Incubator 14-Jun-2017 Completed Startup
1. Grant 01-Mar-2017 Completed Startup

Ilya Pharma Executive Team (5)

Name Title Board Seat Contact Info
Evelina Vågesjö Ph.D Co-Founder & Chief Executive Officer
Peter Frank Chief Operating Officer
Stefan Roos Co-Founder & Chief Technology Officer
Mia Phillipson Co-Founder & Chief Scientific Officer

1 Former Executive

Ilya Pharma Board Members (1)

Name Representing Role Since
Ingemar Kihlström Ph.D Ilya Pharma Chairman 000 0000

Ilya Pharma Investors (6)

To view Ilya Pharma‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
European Commission Government 000 0000 000000 0
Horizon 2020 Government 000 0000 000000 0
Stockholms Affärsänglar Angel Group Minority 000 0000 000000 0
EIT Health Accelerator/Incubator Minority 000 0000 000000 0
ATTD- Advanced Technologies & Treatments for Diabetes Government 000 0000 000000 0

Ready to get started?

Request a free trial